Successful use of telemedicine for evaluation of infantile hemangiomas during the early COVID‐19 pandemic: A cross‐sectional study
Rattachement africain : us, es, ca, cl. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND/OBJECTIVES: The COVID-19 pandemic prompted a rapid expansion in the use of telemedicine. This study aimed to assess the experiences of hemangioma specialists utilizing telemedicine during the COVID-19 pandemic to evaluate and manage infantile hemangiomas (IH), including perceived effectiveness of different modalities and barriers to care delivery. METHODS: Multicenter cross-sectional study asking providers to describe their experiences using telemedicine for initial evaluation of IH from March to September 2020. RESULTS: The study included 281 patients from 15 medical centers internationally. Median time from referral to evaluation was 17 days. Median physician confidence in performing evaluations via telemedicine was 95.0 (IQR 90.0-100.0). Most evaluations were performed via video communication with photographs or audio communication with photographs; when not initially available, photographs were requested in 51.4%. Providers preferred follow-up modalities that included photographs. CONCLUSIONS: Physicians with extensive expertise in managing IH are confident in their abilities to assess and manage IH via telemedicine including initiating treatment in patients without risk factors for beta-blocker therapy. There was a preference for hybrid modalities that included photographs. The data suggest that telemedicine can be effective for managing IH and may decrease wait times and improve specialist reach to underserved areas.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Successful use of telemedicine for evaluation of infantile hemangiomas during the early COVID‐19 pandemic: A cross‐sectional study
- Date Crossref
- 22/06/2022
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of California Department of Dermatology pays non établi dans la noticeUniversité ou école supérieure
-
Medical College of Wisconsin Department of Dermatology pays non établi dans la noticeUniversité ou école supérieure
-
Children's Mercy Hospital Division of Dermatology pays non établi dans la noticeÉtablissement de santé
-
Northwell Health pays non établi dans la noticeÉtablissement de santé
-
Lenox Hill Hospital Department of Pediatrics/Hematology pays non établi dans la noticeÉtablissement de santé
-
Indiana University School of Medicine Department of Dermatology pays non établi dans la noticeUniversité ou école supérieure
-
Indiana University – Purdue University Indianapolis pays non établi dans la noticeUniversité ou école supérieure
-
Baylor College of Medicine Department of Dermatology Texas Children's Hospital pays non établi dans la noticeUniversité ou école supérieure
-
Texas Children's Hospital pays non établi dans la noticeOrganisme public
-
Columbia University Department of Dermatology pays non établi dans la noticeUniversité ou école supérieure
-
University of California System pays non établi dans la noticeUniversité ou école supérieure
-
Nationwide Children's Hospital pays non établi dans la noticeÉtablissement de santé
Department of Dermatology — University of California, Department of Dermatology — Medical College of Wisconsin et Division of Dermatology — Children's Mercy Hospital, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.